Pacira Settles With FDA Over Pain Drug's Off-Label Uses
By John Kennedy ( December 15, 2015, 4:46 PM EST) -- Pacira Pharmaceuticals Inc. said Tuesday it has settled its recent dispute with the U.S. Food and Drug Administration over the agency's allegedly inappropriate attempt to halt the company's off-label marketing of pain medication Exparel....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.